<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00434759</url>
  </required_header>
  <id_info>
    <org_study_id>SP-32000</org_study_id>
    <nct_id>NCT00434759</nct_id>
  </id_info>
  <brief_title>Social Phobia Intervention Study of Mannheim</brief_title>
  <official_title>Evaluation of the Efficacy, Mechanisms of Change and Efficiency of a Stepped-care Program With a Computer-based Self-help Module and Minimal Therapist Contact in Comparison to a Standard Cognitive Therapy for Patients With Social Phobia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Institute of Mental Health, Mannheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Central Institute of Mental Health, Mannheim</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary objective:

      The purpose of this study is to examine efficacy and efficiency of a Stepped Care Program
      (SCP) for patients with Social Phobia in comparison to the standard cognitive therapy for
      Social Phobia according to D.M. Clark.

      Secondary objective:

      Further, it is intended to identify mechanisms of change which mediate treatment outcome and
      to identify differential predictors for therapy success for the two treatment conditions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      With prevalence rates (lifetime) up to 13% in western countries, Social Phobia is one of the
      most frequent mental disorders. Main objective of this clinical trial is the evaluation of
      the efficacy and efficiency of a stepped care program for patients with Social Phobia (SCP)
      as compared to a standard therapy (ST) for patients with social phobia. Both interventions
      are based on the cognitive therapy according to D.M. Clark.

      The SCP starts with a 8-sessions self-help-module with minimal therapist contact via email.
      Patients who do not reach remission after this first step, enter step 2 which consists of 8
      therapy sessions guided by a therapist. If patients are not remitted after that, they receive
      another 8 sessions of therapist-guided cognitive treatment in step 3. So the SCP contains 8,
      16 or 24 sessions of therapy - depending on remission status of the patient. In contrast to
      that, the ST comprises 16 sessions of therapist-guided intervention.

      The diagnostic status of the patients is assessed by blinded clinician raters before
      treatment, after every eighth therapy session, and at 5 follow-up timepoints in order to
      examine the stability of treatment effects (3, 6, 9, 12 and 30 months after the end of
      therapy). Besides efficacy and efficiency of the SCP vs. ST, mechanisms of change and
      differential predictors for therapy outcome will be investigated.

      Hypotheses: We expect that

        1. the SCP is significantly more effective than the ST.

        2. the SCP is significantly more efficient than the ST.

        3. the results referring to the efficacy will be stable up to 30 months after the end of
           treatment(Follow Up Phase).

        4. the SCP will cause less primary and secondary costs than the ST.

        5. successful therapy leads to an improvement in the following areas:

             -  reduction of biased information processing,

             -  reduction of negative thoughts, subjective anxiety, safety behaviors, self-focused
                attention and autonomic arousal in anxiety-provoking situations,

             -  amelioration of verbal and non-verbal social competence in anxiety- provoking
                situations.

      As mediators of change, the factors maintaining social anxiety according to the model of
      Social Phobia by Clark and Wells (1995) will be investigated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Social Interaction Anxiety Scale (SIAS)</measure>
    <time_frame>baseline to post-treatment (on average 24 weeks)</time_frame>
    <description>This scale measures interaction anxiety on a 5-point scale (range of scores is 0-4); the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Social Phobia Scale (SPS)</measure>
    <time_frame>baseline to post-treatment (on average 24 weeks)</time_frame>
    <description>The scale measures social anxiety on a 5-point scale (range of score is 0-4) ; the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Liebowitz Social Anxiety Scale (LSAS)</measure>
    <time_frame>baseline to post-treatment (on average 24 weeks)</time_frame>
    <description>The scale measures social anxiety and avoidance on a 4-point-scale (range of scores is 0-3). Blinded raters assessed social anxiety and avoidance behaviour relating to 24 social situations. Minimum for all 24 situations is 0, maximum for all 24 situations including the assessments for anxiety and avoidance is 144). Lower scores consider better outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Brief Symptom Inventory (BSI)</measure>
    <time_frame>baseline to post-treatment (on average 24 weeks)</time_frame>
    <description>The scale measures general psychopathology on 53 items on a 5-point scale (range of scores is 0-4). Minimum for all 53 items is 0, maximum is 212. Lower scores consider better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change on Baseline in Center for Epidemiologic Studies Depression Scale (CES-D)</measure>
    <time_frame>baseline to post-treatment (on average 24 weeks)</time_frame>
    <description>The scale measures depressive symptoms on 20 items on a 4-point scale (range of scores is 0-3; minimum for all 20 items is 0, maximum 60). Lower scores consider better outcome.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">89</enrollment>
  <condition>Social Phobia</condition>
  <arm_group>
    <arm_group_label>SCP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SCP is a stepped-care program with a self-help module with minimal therapist contact (8 sessions) as first step, followed by therapist-guided intervention depending on status of remission (8 sessions up to a maximum of 16 sessions).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ST</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A standard therapy which means a therapist-guided intervention with 16 sessions face-to-face therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>cognitive therapy</intervention_name>
    <description>changing safety behaviors, self-focused attention, and automatic negative thoughts in anxiety-provoking situations via cognitive techniques, for example role plays and behavioral experiments</description>
    <arm_group_label>ST</arm_group_label>
    <other_name>cognitive therapy of social phobia according to D.M. Clark</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>stepped care program based on cognitive therapy</intervention_name>
    <description>starting with a digital-video-disk-based (DVD-based) self-help module (8 Sessions) followed by face-to-face-therapy including 8 or 16 sessions depending on remission status; including: changing safety behaviors, self-focused attention, and automatic negative thoughts in anxiety-provoking situations via cognitive techniques, for example role plays and behavioral experiments</description>
    <arm_group_label>SCP</arm_group_label>
    <other_name>based on cognitive therapy for social phobie by Clark &amp; Wells (1995)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Social Phobia according to the criteria of the Diagnostic and Statistical
             Manual of Mental Disorders IV (DSM-IV)

          -  Duration of the disorder at least 1 year

          -  Severity of symptomatology according to at least one of two self-report measures for
             social anxiety above Cut-Off: Social Interaction Anxiety Scale (SIAS: value of 26 or
             more) and / or Social Phobia Scale (SPS: value of 17 or more)

          -  Age: 18-60

          -  Written Informed Consent

        Exclusion Criteria:

          -  Social Phobia is not the main diagnosis

          -  Mental Retardation

          -  Lifetime Diagnoses: Schizophreniform Disorder, Bipolar Affective Disorder

          -  Acute Diagnoses: severe Major Depression Episode, severe Anorexia Nervosa, Substance-,
             Drug - or Alcohol-Dependence, life-threatening suicidal crisis

          -  Psychotropic medication (except stable treatment with antidepressant since 3 months
             before study start: medication and dosage has to be stable during the entire study
             duration)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Bohus, MD</last_name>
    <role>Study Director</role>
    <affiliation>Central Institute of Mental Health in Mannheim</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Institute of Mental Health</name>
      <address>
        <city>Mannheim</city>
        <state>Baden-WÃ¼rttemberg</state>
        <zip>68159</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2007</study_first_submitted>
  <study_first_submitted_qc>February 9, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2007</study_first_posted>
  <results_first_submitted>November 29, 2011</results_first_submitted>
  <results_first_submitted_qc>October 28, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 28, 2012</results_first_posted>
  <last_update_submitted>October 28, 2012</last_update_submitted>
  <last_update_submitted_qc>October 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>randomized controlled trial</keyword>
  <keyword>stepped-care program</keyword>
  <keyword>cognitive therapy of social phobia according to D.M. Clark</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phobic Disorders</mesh_term>
    <mesh_term>Phobia, Social</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Stepped Care Program</title>
          <description>stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission</description>
        </group>
        <group group_id="P2">
          <title>Standardtherapy</title>
          <description>standard therapy (therapist-guided intervention only)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>family affairs</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Stepped Care Program</title>
          <description>stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission</description>
        </group>
        <group group_id="B2">
          <title>Standardtherapy</title>
          <description>standard therapy (therapist-guided intervention only)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="46"/>
            <count group_id="B2" value="43"/>
            <count group_id="B3" value="89"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.26" spread="10.47"/>
                    <measurement group_id="B2" value="38.47" spread="10.26"/>
                    <measurement group_id="B3" value="37.84" spread="10.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Social Interaction Anxiety Scale (SIAS)</title>
        <description>This scale measures interaction anxiety on a 5-point scale (range of scores is 0-4); the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.</description>
        <time_frame>baseline to post-treatment (on average 24 weeks)</time_frame>
        <population>Intention-to-Treat</population>
        <group_list>
          <group group_id="O1">
            <title>Stepped Care Program</title>
            <description>stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission (8 sessions up to 24 sessions)</description>
          </group>
          <group group_id="O2">
            <title>Standardtherapy</title>
            <description>standard therapy (therapist-guided intervention only; 16 sessions)</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Social Interaction Anxiety Scale (SIAS)</title>
          <description>This scale measures interaction anxiety on a 5-point scale (range of scores is 0-4); the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.</description>
          <population>Intention-to-Treat</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.13" spread="14.26"/>
                    <measurement group_id="O2" value="48.94" spread="11.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post-treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.85" spread="14.86"/>
                    <measurement group_id="O2" value="33.35" spread="16.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>priori threshold for statistical significance is 0.05 p-value is not adjusted for multiple comparisons</p_value_desc>
            <method>ANOVA</method>
            <method_desc>We report the interaction effect.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>5.82</param_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>The reported interaction effect is significant (p&lt; .05) in favour of standard therapy.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Brief Symptom Inventory (BSI)</title>
        <description>The scale measures general psychopathology on 53 items on a 5-point scale (range of scores is 0-4). Minimum for all 53 items is 0, maximum is 212. Lower scores consider better outcome.</description>
        <time_frame>baseline to post-treatment (on average 24 weeks)</time_frame>
        <population>Intention-to-Treat</population>
        <group_list>
          <group group_id="O1">
            <title>Stepped Care Program</title>
            <description>stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission</description>
          </group>
          <group group_id="O2">
            <title>Standardtherapy</title>
            <description>standard therapy (therapist-guided intervention only)</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Brief Symptom Inventory (BSI)</title>
          <description>The scale measures general psychopathology on 53 items on a 5-point scale (range of scores is 0-4). Minimum for all 53 items is 0, maximum is 212. Lower scores consider better outcome.</description>
          <population>Intention-to-Treat</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.00" spread="0.59"/>
                    <measurement group_id="O2" value="0.90" spread="0.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post-treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.71" spread="0.51"/>
                    <measurement group_id="O2" value="0.51" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>priori threshold for statistical significance is 0.05 p-value ist not adjusted for multiple comparisons</p_value_desc>
            <method>ANOVA</method>
            <method_desc>we report the interaction effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.24</param_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>The reported interaction effect is not significant.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change on Baseline in Center for Epidemiologic Studies Depression Scale (CES-D)</title>
        <description>The scale measures depressive symptoms on 20 items on a 4-point scale (range of scores is 0-3; minimum for all 20 items is 0, maximum 60). Lower scores consider better outcome.</description>
        <time_frame>baseline to post-treatment (on average 24 weeks)</time_frame>
        <population>Intention-to-Treat</population>
        <group_list>
          <group group_id="O1">
            <title>Stepped Care Program</title>
            <description>stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission</description>
          </group>
          <group group_id="O2">
            <title>Standardtherapy</title>
            <description>standard therapy (therapist-guided intervention only)</description>
          </group>
        </group_list>
        <measure>
          <title>Change on Baseline in Center for Epidemiologic Studies Depression Scale (CES-D)</title>
          <description>The scale measures depressive symptoms on 20 items on a 4-point scale (range of scores is 0-3; minimum for all 20 items is 0, maximum 60). Lower scores consider better outcome.</description>
          <population>Intention-to-Treat</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.48" spread="9.97"/>
                    <measurement group_id="O2" value="21.47" spread="11.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post-treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.20" spread="10.26"/>
                    <measurement group_id="O2" value="14.28" spread="9.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>p-value is not adjusted for multiple comparisons</p_value_desc>
            <method>ANOVA</method>
            <method_desc>we report the interaction effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.99</param_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>The reported interaction effect is not significant.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Social Phobia Scale (SPS)</title>
        <description>The scale measures social anxiety on a 5-point scale (range of score is 0-4) ; the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.</description>
        <time_frame>baseline to post-treatment (on average 24 weeks)</time_frame>
        <population>Intention-to-Treat</population>
        <group_list>
          <group group_id="O1">
            <title>Stepped Care Program</title>
            <description>stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission</description>
          </group>
          <group group_id="O2">
            <title>Standardtherapy</title>
            <description>standard therapy (therapist-guided intervention only)</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Social Phobia Scale (SPS)</title>
          <description>The scale measures social anxiety on a 5-point scale (range of score is 0-4) ; the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.</description>
          <population>Intention-to-Treat</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.85" spread="14.97"/>
                    <measurement group_id="O2" value="33.95" spread="13.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post-treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.89" spread="17.41"/>
                    <measurement group_id="O2" value="17.58" spread="13.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>priori threshold for statistical significance is 0.05 p-value ist not adjusted for multiple comparisons</p_value_desc>
            <method>ANOVA</method>
            <method_desc>we report the interaction effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>3.43</param_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>The reported interaction is not significant.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Liebowitz Social Anxiety Scale (LSAS)</title>
        <description>The scale measures social anxiety and avoidance on a 4-point-scale (range of scores is 0-3). Blinded raters assessed social anxiety and avoidance behaviour relating to 24 social situations. Minimum for all 24 situations is 0, maximum for all 24 situations including the assessments for anxiety and avoidance is 144). Lower scores consider better outcome.</description>
        <time_frame>baseline to post-treatment (on average 24 weeks)</time_frame>
        <population>Intention-to-Treat</population>
        <group_list>
          <group group_id="O1">
            <title>Stepped Care Program</title>
            <description>stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission</description>
          </group>
          <group group_id="O2">
            <title>Standardtherapy</title>
            <description>standard therapy (therapist-guided intervention only)</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Liebowitz Social Anxiety Scale (LSAS)</title>
          <description>The scale measures social anxiety and avoidance on a 4-point-scale (range of scores is 0-3). Blinded raters assessed social anxiety and avoidance behaviour relating to 24 social situations. Minimum for all 24 situations is 0, maximum for all 24 situations including the assessments for anxiety and avoidance is 144). Lower scores consider better outcome.</description>
          <population>Intention-to-Treat</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.46" spread="23.61"/>
                    <measurement group_id="O2" value="60.58" spread="19.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post-treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.22" spread="23.49"/>
                    <measurement group_id="O2" value="31.84" spread="21.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>priori threshold for statistical significance ist 0.05 p-value ist nor adjusted for multiple comparisons</p_value_desc>
            <method>ANOVA</method>
            <method_desc>we report the interaction effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>6.86</param_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>The reported interaction effect is significant (p &lt; .05) in favour of standard therapy</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>No serious and/or other adverse events were assessed.</desc>
      <group_list>
        <group group_id="E1">
          <title>Stepped Care Program</title>
          <description>stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission</description>
        </group>
        <group group_id="E2">
          <title>Standardtherapy</title>
          <description>standard therapy (therapist-guided intervention only)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Martin Bohus</name_or_title>
      <organization>Central Institute of Mental Health, Mannheim, Germany</organization>
      <phone>+49 621 1703 4002</phone>
      <email>martin.bohus@zi-mannheim.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

